Abstract:REDFV on DUAV represents an ominous and severe fetal condition with an adverse pregnancy outcome, especially in conditions associated with preeclampsia and/or intrauterine growth retardation. Intensive and frequent surveillance and aggressive management at the appropriate time would improve perinatal outcome.
“…The use of Doppler technique in obstetrics for evaluation of fetal well‐being is now generally accepted as an important clinical tool in the decision‐making, mainly in high‐risk pregnancies (1–3). To understand the physical characteristics of the blood flow velocity waveform (FVW) in the umbilical arteries, knowledge of their anatomy is important.…”
By using angiography we were able to demonstrate the variable anatomy of the anastomosis of Hyrtl. We found the occurrence and width of the anastomosis was correlated to the symmetry in size between the supply areas of each umbilical artery.
“…The use of Doppler technique in obstetrics for evaluation of fetal well‐being is now generally accepted as an important clinical tool in the decision‐making, mainly in high‐risk pregnancies (1–3). To understand the physical characteristics of the blood flow velocity waveform (FVW) in the umbilical arteries, knowledge of their anatomy is important.…”
By using angiography we were able to demonstrate the variable anatomy of the anastomosis of Hyrtl. We found the occurrence and width of the anastomosis was correlated to the symmetry in size between the supply areas of each umbilical artery.
The A/B or C/D ratio can be used for quantification of the reverse end-diastolic flow waveforms in the umbilical artery and may offer additional information to the evaluation of fetal condition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.